Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Knighty Tin who wrote (96731)	7/18/2002 8:15:08 PM
From: ild	Read Replies (1) \| Respond to of 132070

Press Release SOURCE: Vasomedical, Inc. New Data Show Significant Reduction in Angina Severity Maintained At Two Years in Heart Failure Patients Using Vasomedical's EECP Therapy More Than 75 Percent of Patients in Study Do Not Experience Worsening of Heart Failure Symptoms During Two-Year Follow-Up Period biz.yahoo.com EDIT: The only thing which is missing with VASO is massive insider buying. I guess they are in a quiet period and can't buy (or sell).